My assignments for Rheumatology Network
include reporting on recent scientific studies about rheumatoid
arthritis and other related diseases. This month I also covered sessions and abstracts for the American College of Rheumatology Annual Meeting.
Although these articles are
intended primarily for a physician audience (and thus can get a bit
technical and jargon-y) I know patients are also interested in
scientific advances - so I still want to share links to these articles!
But if you ever have additional questions, please don't hesitate to let
me know!
A recent systematic review of literature found no validated and widely accepted biomarker.
Up-to-date guidelines were developed to help improve patient outcomes.
The pros and cons of using biosimilar medications shaped the "Great Debate" at this year's ACR/ARHP Annual Meeting.
The ACR/ARHP Annual Meeting provided a research update on surrounding issues and strategies for helping patients.
New evidence is reassuring for women with rheumatoid arthritis who need treatment with a biologic throughout pregnancy.
The role of legalized marijuana in society and evidence-based medicine was examined at the ACR/ARHP Annual Meeting.
Some physicians have shown reluctance to use these agents for patients who have rheumatoid arthritis and a previous cancer diagnosis.
With a drug holiday, patients with rheumatoid arthritis could improve their response to influenza vaccinations without increasing disease activity.
National initiatives are designed to provide education, advance research, solve the opioid crisis, and help patients.
This tool may be used to reduce stressors, improve well-being, and decrease symptoms.
No comments:
Post a Comment